share_log

Bausch Health Companies Sees Unusually High Options Volume (NYSE:BHC)

Bausch Health Companies Sees Unusually High Options Volume (NYSE:BHC)

博世健康公司看到异常高的期权成交量(纽约证券交易所代码：BHC)
kopsource ·  2022/09/29 00:22

Bausch Health Companies Inc. (NYSE:BHC – Get Rating) was the target of some unusual options trading on Wednesday. Stock traders acquired 40,728 call options on the company. This represents an increase of approximately 104% compared to the typical volume of 20,011 call options.

博世健康公司(纽约证券交易所代码：BHC-GET评级)周三成为一些不同寻常的期权交易的目标。股票交易员获得了该公司40,728份看涨期权。与20,011份认购期权的典型成交量相比，这一数字增加了约104%。

Analyst Upgrades and Downgrades

分析师升级和下调评级

A number of equities analysts recently weighed in on the company. Truist Financial lowered Bausch Health Companies from a "buy" rating to a "hold" rating in a research report on Thursday, July 28th. Piper Sandler reduced their price objective on Bausch Health Companies from $7.00 to $6.00 and set a "neutral" rating for the company in a research note on Friday, September 9th. Royal Bank of Canada increased their price objective on Bausch Health Companies from $4.50 to $8.00 and gave the stock a "sector perform" rating in a research note on Thursday, September 1st. Finally, JPMorgan Chase & Co. downgraded Bausch Health Companies from an "overweight" rating to a "neutral" rating in a research note on Thursday, July 28th. Six analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $10.60.

一些股票分析师最近对该公司进行了分析。7月28日周四，Truist Financial在一份研究报告中将博世健康公司的评级从“买入”下调至“持有”。派珀·桑德勒在9月9日星期五的一份研究报告中将他们对博世健康公司的目标价从7.00美元下调至6.00美元，并将该公司的评级定为“中性”。9月1日周四，加拿大皇家银行在一份研究报告中将博世健康公司的目标价从4.50美元上调至8.00美元，并给予该股“行业表现”评级。最后，在7月28日星期四的一份研究报告中，摩根大通将博世健康公司的评级从“增持”下调至“中性”。六位分析师对该股的评级为持有，一位分析师对该公司的评级为买入。根据MarketBeat.com的数据，该公司目前的平均评级为持有，平均目标价为10.60美元。

Get
到达
Bausch Health Companies
博世健康公司
alerts:
警报：

Institutional Trading of Bausch Health Companies

博世健康公司的机构交易

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Blueshift Asset Management LLC acquired a new stake in shares of Bausch Health Companies during the 1st quarter worth approximately $464,000. Metis Global Partners LLC acquired a new stake in shares of Bausch Health Companies during the 1st quarter worth approximately $254,000. Woodline Partners LP grew its holdings in shares of Bausch Health Companies by 1.1% during the 1st quarter. Woodline Partners LP now owns 1,013,462 shares of the company's stock worth $23,158,000 after purchasing an additional 10,944 shares in the last quarter. Guardian Capital Advisors LP grew its holdings in shares of Bausch Health Companies by 73.8% during the 1st quarter. Guardian Capital Advisors LP now owns 63,690 shares of the company's stock worth $1,447,000 after purchasing an additional 27,040 shares in the last quarter. Finally, Crescent Park Management L.P. acquired a new stake in shares of Bausch Health Companies during the 1st quarter worth approximately $5,257,000. Institutional investors and hedge funds own 70.07% of the company's stock.

一些对冲基金和其他机构投资者最近增持或减持了该业务的股份。BluesShift Asset Management LLC在第一季度收购了博世健康公司价值约46.4万美元的新股。梅蒂斯全球合伙公司在第一季度收购了博世健康公司价值约25.4万美元的新股份。Woodline Partners LP在第一季度增持了博世健康公司的股票1.1%。Woodline Partners LP在上个季度购买了10,944股后，现在拥有1,013,462股该公司股票，价值23,158,000美元。第一季度，Guardian Capital Advisors LP对博世健康公司股票的持有量增加了73.8%。Guardian Capital Advisors LP现在拥有63,690股该公司股票，价值1,447,000美元，上个季度又购买了27,040股。最后，新月公园管理公司在第一季度收购了博世健康公司价值约5,257,000美元的新股份。机构投资者和对冲基金持有该公司70.07%的股票。

Bausch Health Companies Stock Performance

博世健康公司股票表现

Shares of BHC stock traded up $0.31 during trading on Wednesday, reaching $7.47. The company had a trading volume of 5,205,571 shares, compared to its average volume of 6,796,660. The company has a market capitalization of $2.70 billion, a PE ratio of 62.26 and a beta of 1.21. The firm's 50 day simple moving average is $6.46 and its two-hundred day simple moving average is $11.81. The company has a debt-to-equity ratio of 85.63, a current ratio of 1.08 and a quick ratio of 0.87. Bausch Health Companies has a one year low of $4.00 and a one year high of $29.31.
在周三的交易中，六六六的股票价格上涨了0.31美元，达到7.47美元。该公司的成交量为5205,571股，而其平均成交量为6796,660股。该公司市值为27亿美元，市盈率为62.26倍，贝塔系数为1.21。该公司的50日简单移动均线切入位为6.46美元，200日简单移动均线切入位为11.81美元。该公司的债务权益比为85.63，流动比率为1.08，速动比率为0.87。博世健康公司的一年低点为4.00美元，一年高位为29.31美元。

Bausch Health Companies Company Profile

博世健康公司简介

(Get Rating)

(获取评级)

Bausch Health Companies Inc, together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.

博世健康公司与其子公司一起开发、制造和营销一系列药物、医疗器械和非处方药(OTC)产品，主要用于眼睛健康、胃肠病和皮肤病等治疗领域。该公司通过五个部门经营：博士伦、沙利克斯、国际处方、正畸皮肤科和多元化产品。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Bausch Health Companies (BHC)
  • Can United Natural Foods Fight Both Inflation and the Fed?
  • Mullen Automotive Is Ready To Get In Gear
  • Cracker Barrel: A Tasty Treat Or Bad Apple?
  • Defensive Stocks For A Volatile Market
  • Will UPS Be Next to Deliver a Warning?
  • 免费获取StockNews.com关于博世健康公司(BHC)的研究报告
  • 联合天然食品能同时对抗通胀和美联储吗？
  • 马伦汽车已做好准备投入使用
  • 饼干桶：可口的款待还是坏苹果？
  • 防御性股票应对动荡的市场
  • UPS会成为下一个发出警告的公司吗？

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.

接受博世健康公司每日新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对博世健康公司和相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发